Skip to main content
. Author manuscript; available in PMC: 2013 Jul 23.
Published in final edited form as: Breast Cancer Res Treat. 2011 Sep 21;133(2):459–471. doi: 10.1007/s10549-011-1766-x

Fig. 5.

Fig. 5

β1 integrin mediates the protective effect of LM05-F-conditioned media, but EGFR is not involved in FN’s protective effect. a To establish whether β1 integrin played a role in LM05-F-conditioned media (FCM) induced tamoxifen resistance, LM05-E cells were plated in the presence of non-conditioned media (NCM) or FCM and treated with 10 nM estradiol (E2) or estradiol plus 1 µM 4-OH-tamoxifen (E2 + T). The addition of AIIB2 reversed the protective effect of FCM on E2 + T treated cells, but did not significantly affect the E2 treated cells; (**P<0.01; ***P<0.001). b To test the involvement of EGFR on FN’s protective effect, LM05-E cells were cultured on BSA (control) or FN and treated for 48 h with 10 nM estradiol (E2) or 10 nM E2 + 1 µM 4-OH-tamoxifen (E2 + T) in the presence of the EGFR inhibitor AG1478 (AG; 6.4 µM). AG1478 did not reverse the protective effect of FN (***P<0.001). One of at least two experiments is shown